| Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile. SM Bueno, K Abarca, PA González, N Gálvez, JA Soto, LF Duarte, ... Clin. infect. dis, 2021 | 109* | 2021 |
| Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial SM Bueno, K Abarca, PA González, NMS Gálvez, JA Soto, LF Duarte, ... MedRxiv, 2021 | 72 | 2021 |
| SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments G Canedo-Marroquín, F Saavedra, CA Andrade, RV Berrios, ... Frontiers in Immunology 11, 2020 | 53 | 2020 |
| Immune response during hantavirus diseases. Implications for immunotherapies and vaccine design. F Saavedra, FE Díaz, A Retamal‐Díaz, C Covián, PA González, ... Immunology, 2021 | 25 | 2021 |
| Correlación entre criterios clínicos y de laboratorio de casos notificados por sospecha de hantavirosis y el resultado de la técnica de referencia M Navarrete, M Hott, J Caroca, L Leyton, N Venegas, K Ismail, ... Revista chilena de infectología 33 (3), 275-281, 2016 | 22 | 2016 |
| Serological evidence of hantavirus infection in apparently healthy people from rural and slum communities in southern Chile C Muñoz-Zanzi, F Saavedra, C Otth, L Domancich, M Hott, P Padula Viruses 7 (4), 2006-2013, 2015 | 17 | 2015 |
| Differential CD4 T regulatory cell phenotype induced by Andes hantavirus glycoprotein F Saavedra, JL Garrido, F Fuentes-Villalobos, M Calvo, R Riquelme, ... Frontiers in cellular and infection microbiology 10, 430, 2020 | 6 | 2020 |
| Correlation between clinical and laboratory criteria of suspected hantavirus cases and the results of the reference diagnostic technique M Navarrete, M Hott, J Caroca, L Leyton, N Venegas, K Ismail, ... Revista chilena de infectologia: organo oficial de la Sociedad Chilena de …, 2016 | 2 | 2016 |
